产品分类导航
利拉鲁肽原料
利拉鲁肽原料
利拉鲁肽原料

利拉鲁肽原料

更新时间:2026-02-27

价格:
CAS号: 204656-20-2
药典: 中国药典,美国药典,欧洲药典
级别: 药用级
立即询盘
收藏

产品详情

产品名称: 利拉鲁肽原料
产品分类: 激素类
CAS号: 204656-20-2
药典: 中国药典,美国药典,欧洲药典
级别: 药用级
产品关键词: 利拉鲁肽,liraglutide,204656-20-2,GLP-1
是否为生产商:
产品包装规格: 根据需求
包装材质:
最低订购量: 50G
供货能力: 50KGS
付款方式: TT IN ADVANCE
交货周期: 现货
主要销售市场: 北美洲,中/南美洲,西欧,东欧,大洋洲,亚洲,中东,非洲
是否提供样品:

产品描述:

这是人胰高血糖素样肽-1(GLP-1)的合成类似物,并用作GLP-1受体Agonist1。利拉鲁肽通过将精氨酸代替341位的赖氨酸是与天然人类GLP-1同源的97%。通过将C-16脂肪酸(棕榈酸)与谷氨酸间隔剂连接在肽前蛋白26的剩余赖氨酸残基上的C-16脂肪酸(棕榈酸)来制造。

It is a synthetic analogue of human glucagon-like peptide-1 (GLP-1) and acts as a GLP-1 receptor Agonist1. Liraglutide is 97% homologous to natural human GLP-1 by substituting arginine for lysine at position 341. It is manufactured by connecting the C-16 fatty acid (palmitic acid) with a glutamate spacer to the C-16 fatty acid (palmitic acid) on the remaining lysine residue of the peptide preprotein 26.

补充信息:
利拉鲁肽原料的分子式为C₁₇₂H₂₆₅N₄₃O₅₁,CAS号为204656-20-2。它是一种GLP-1受体激动剂,主要用于治疗2型糖尿病和肥胖症。利拉鲁肽通过模拟肠道激素GLP-1的作用,增强胰岛素分泌,抑制胰高血糖素释放,延缓胃排空,从而有效控制血糖水平和减轻体重。其长效特性使其成为糖尿病管理和体重控制的重要药物。
补充信息由AI自动生成,仅供参考。

公司简介

我公司的总公司——亿帆医药股份有限公司,简称:亿帆医药,证券代码:002019。是专注医药健康领域的创新型研发生产企业,致力于以经典发现与经典创新并举,对可能性方案展开科学验证,为全球医药健康事业贡献更新的专业力量。围绕大分子、小分子、合成生物、特色中药四大核心业务,我们在旧金山、上海、北京、杭州、合肥搭建了五大自主科研中心,充分协同海内外优质创新资源,持续加码创新研发,初步形成了符合临床需求并具有商业价值的差异化、多元化、有竞争力的产品研发管线,近50个在研产品,覆盖创新药、生仿药、仿制药、中成药、合成生物等。我公司自主生产的大分子生物原料药及中间体:生长激素、司美格鲁肽、利拉鲁肽、特立帕肽、甘精胰岛素、门冬胰岛素、德谷胰岛素 以及各类工具酶等面向国际市场推广。我公司自主生产的泛酸钙、泛醇、beta-丙酸、泛解酸内酯、3-氨基丙醇等产品,技术、品质和销量均国际领先!我公司也分销代理维生素K1、二氮嗪、缩宫素、重酒石酸去甲肾上腺素、间苯三酚、依克多因、麦角硫因、阿基瑞林等原料药及医美产品。欢迎友好互利、双赢合作!Our company -- Yifan Pharmaceutical Co., LTD., referred to as: Yifan Pharmaceutical, stock code: 002019. Is an innovative R & D and production enterprise focusing on the field of medicine and health, committed to classical discovery and classic innovation, scientific verification of possible solutions, and contribution to the global medical and health industry. Focusing on the four core businesses of macromolecule, small molecule, synthetic biology and specialty Chinese medicine, we have set up five independent scientific research centers in San Francisco, Shanghai, Beijing, Hangzhou and Hefei, fully cooperating with high-quality innovation resources at home and abroad, continuously increasing innovative research and development, and initially formed a differentiated, diversified and competitive product research and development pipeline that meets clinical needs and has commercial value. Nearly 50 products are under research, covering innovative drugs, imitation drugs, generic drugs, proprietary Chinese medicines, synthetic biology and so on.The macromolecular biological APIs and intermediates independently produced by YIFAN: Human growth hormone(Somatropin), HGH,Semaglutide, Liraglutide, Teriparatide, Insulin Glargine, Insulin Aspartate,Insulin Aspart, Insulin Degludec and various Tool Enzymes are marketed to the international market.Our independent production of calcium pantothenate, panthenol, beta-propionic acid, pantothenolactone, 3-amino-propanol and other products, technology, quality and sales are leading in the world!Our company also distributes and agents vitamin K1, diazine, oxytocin, norepinephrine bitartrate, phloroglucinol, ecdoin, ergothioneine, acirirelin and other raw materials and medical products.Welcome friendly, mutually beneficial and win-win cooperation!
注册资本:
企业规模(人):
业务类型:
成立日期:
年销售额:
主营产品类别:

该公司其他产品

somatropin hgh
somatropin hgh
这是人胰高血糖素样肽-1(GLP-1)的合成类似物,并用作GLP-1受体Agonist1。利拉鲁肽通过将精氨酸代替341位的赖氨酸是与天然人类GLP-1同源的97%。通过将C-16脂肪酸(棕榈酸)与谷氨酸间隔剂连接在肽前蛋白26的剩余赖氨酸残基上的C-16脂肪酸(棕榈酸)来制造。 It is a synthetic analogue of human glucagon-like peptide-1 (GLP-1) and acts as a GLP-1 receptor Agonist1. Liraglutide is 97% homologous to natural human GLP-1 by substituting arginine for lysine at position 341. It is manufactured by connecting the C-16 fatty acid (palmitic acid) with a glutamate spacer to the C-16 fatty acid (palmitic acid) on the remaining lysine residue of the peptide preprotein 26.
recombinant hgh
recombinant hgh
这是人胰高血糖素样肽-1(GLP-1)的合成类似物,并用作GLP-1受体Agonist1。利拉鲁肽通过将精氨酸代替341位的赖氨酸是与天然人类GLP-1同源的97%。通过将C-16脂肪酸(棕榈酸)与谷氨酸间隔剂连接在肽前蛋白26的剩余赖氨酸残基上的C-16脂肪酸(棕榈酸)来制造。 It is a synthetic analogue of human glucagon-like peptide-1 (GLP-1) and acts as a GLP-1 receptor Agonist1. Liraglutide is 97% homologous to natural human GLP-1 by substituting arginine for lysine at position 341. It is manufactured by connecting the C-16 fatty acid (palmitic acid) with a glutamate spacer to the C-16 fatty acid (palmitic acid) on the remaining lysine residue of the peptide preprotein 26.
hgh
hgh
这是人胰高血糖素样肽-1(GLP-1)的合成类似物,并用作GLP-1受体Agonist1。利拉鲁肽通过将精氨酸代替341位的赖氨酸是与天然人类GLP-1同源的97%。通过将C-16脂肪酸(棕榈酸)与谷氨酸间隔剂连接在肽前蛋白26的剩余赖氨酸残基上的C-16脂肪酸(棕榈酸)来制造。 It is a synthetic analogue of human glucagon-like peptide-1 (GLP-1) and acts as a GLP-1 receptor Agonist1. Liraglutide is 97% homologous to natural human GLP-1 by substituting arginine for lysine at position 341. It is manufactured by connecting the C-16 fatty acid (palmitic acid) with a glutamate spacer to the C-16 fatty acid (palmitic acid) on the remaining lysine residue of the peptide preprotein 26.
亿帆医药股份有限公司
注册资本100,000,000至249,999,999
公司地址
浙江省杭州市浙江省杭州市临安区锦城街道琴山50号
联系人
查看联系方式
快速询盘
询盘主题
请输入询盘主题
询盘信息
请输入询盘信息
快速发送询盘
2006-2026 上海博华国际展览有限公司版权所有(保留一切权利) 沪ICP备05034851号-57